Veromca Lin

Director of Preclinical Research @ Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)

About

I am the Director of Preclinical Research at Arcutis Biotherapeutics and have over 20 years of experience in drug discovery and preclinical research. My focus is on evaluating the safety, efficacy, and pharmacokinetics (PK) of drug candidates to ensure they meet the rigorous standards required for clinical trials. As a leader, I am passionate about mentoring and guiding research teams to deliver high-quality, data-driven results that advance new therapies. In my current role at Arcutis, I oversee preclinical research programs that support the development of innovative dermatology treatments. I lead a team of talented scientists who conduct in vitro and in vivo studies, including toxicology evaluations, efficacy testing, and PK studies to generate critical data for IND applications. My team's work directly impacts the progression of our drug candidates from the lab into clinical trials and plays a key role in shaping the company's R&D strategy. I am committed to fostering an environment of scientific excellence and innovation and work closely with cross-functional teams to ensure that our preclinical research efforts are aligned with our clinical goals. With expertise in drug development, safety pharmacology and regulatory requirements, I am committed to helping bring breakthrough therapies to patients who need them most.

Country

City

United States

Industry

Biotechnology

Skill

Experience

Director of Preclinical Research

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)

2011-5 - Present · 15 yrs 4 mos

Lead and manage a team of scientists responsible for evaluating the safety, efficacy, and pharmacokinetics of drug candidates in dermatology and other therapeutic areas. Oversee preclinical studies including in vivo and in vitro toxicology evaluations, pharmacokinetic analyses and efficacy testing in support of clinical trial design and IND applications. Design and implement preclinical study strategies to ensure efficient data generation and fulfillment of necessary regulatory criteria for IND applications. Work closely with the clinical development team to integrate preclinical study results with clinical development objectives to ensure a smooth transition of drug development from the preclinical to the clinical phase. Perform data analysis and interpretation to present findings to senior leadership and stakeholders to inform decision making on drug candidate advancement. Mentor and train junior scientists to foster a collaborative environment that encourages scientific excellence and professional growth within the team. Manage external partnerships with contract research organizations (CROs) and academic collaborators to enhance research capabilities and accelerate drug development timelines. Participate in the writing and review of scientific reports, regulatory submissions and scientific publications to support the advancement of the company's therapeutic pipeline.

Drug safety research scientists

Amgen

2005-8 - 2011-6 · 5 yrs 11 mos

United States

Specializes in safety pharmacology and toxicology studies of biological and small molecule drugs to support early and late stage drug development. Perform pharmacokinetic and pharmacodynamic studies to assess the absorption, distribution, metabolism and excretion (ADME) properties of drug candidates. Work closely with the toxicology team to assess potential safety risks of drug candidates in preclinical models, including assessment of potential organ toxicity and off-target effects. Collaborate with cross-functional teams such as Drug Development and Regulatory Affairs to ensure preclinical data supports regulatory filings and clinical trial design.